These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

642 related articles for article (PubMed ID: 26080838)

  • 21. MicroRNA-296-5p (miR-296-5p) functions as a tumor suppressor in prostate cancer by directly targeting Pin1.
    Lee KH; Lin FC; Hsu TI; Lin JT; Guo JH; Tsai CH; Lee YC; Lee YC; Chen CL; Hsiao M; Lu PJ
    Biochim Biophys Acta; 2014 Sep; 1843(9):2055-66. PubMed ID: 24915000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-15a and miR-16 affect the angiogenesis of multiple myeloma by targeting VEGF.
    Sun CY; She XM; Qin Y; Chu ZB; Chen L; Ai LS; Zhang L; Hu Y
    Carcinogenesis; 2013 Feb; 34(2):426-35. PubMed ID: 23104180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-539 inhibits prostate cancer progression by directly targeting SPAG5.
    Zhang H; Li S; Yang X; Qiao B; Zhang Z; Xu Y
    J Exp Clin Cancer Res; 2016 Apr; 35():60. PubMed ID: 27037000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The miR-203/SNAI2 axis regulates prostate tumor growth, migration, angiogenesis and stemness potentially by modulating GSK-3β/β-CATENIN signal pathway.
    Tian X; Tao F; Zhang B; Dong JT; Zhang Z
    IUBMB Life; 2018 Mar; 70(3):224-236. PubMed ID: 29389061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of miR-26a-5p promotes proliferation, migration, and invasion in prostate cancer through negatively regulating SERBP1.
    Guo K; Zheng S; Xu Y; Xu A; Chen B; Wen Y
    Tumour Biol; 2016 Sep; 37(9):12843-12854. PubMed ID: 27449037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-361-5p acts as a tumor suppressor in prostate cancer by targeting signal transducer and activator of transcription-6(STAT6).
    Liu D; Tao T; Xu B; Chen S; Liu C; Zhang L; Lu K; Huang Y; Jiang L; Zhang X; Huang X; Zhang L; Han C; Chen M
    Biochem Biophys Res Commun; 2014 Feb; 445(1):151-6. PubMed ID: 24491557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-182-5p promotes cell invasion and proliferation by down regulating FOXF2, RECK and MTSS1 genes in human prostate cancer.
    Hirata H; Ueno K; Shahryari V; Deng G; Tanaka Y; Tabatabai ZL; Hinoda Y; Dahiya R
    PLoS One; 2013; 8(1):e55502. PubMed ID: 23383207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. lncRNA H19/miR-675 axis represses prostate cancer metastasis by targeting TGFBI.
    Zhu M; Chen Q; Liu X; Sun Q; Zhao X; Deng R; Wang Y; Huang J; Xu M; Yan J; Yu J
    FEBS J; 2014 Aug; 281(16):3766-75. PubMed ID: 24988946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
    Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
    Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-940 suppresses prostate cancer migration and invasion by regulating MIEN1.
    Rajendiran S; Parwani AV; Hare RJ; Dasgupta S; Roby RK; Vishwanatha JK
    Mol Cancer; 2014 Nov; 13():250. PubMed ID: 25406943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-326 functions as a tumor suppressor in human prostatic carcinoma by targeting Mucin1.
    Liang X; Li Z; Men Q; Li Y; Li H; Chong T
    Biomed Pharmacother; 2018 Dec; 108():574-583. PubMed ID: 30243091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-20a promotes prostate cancer invasion and migration through targeting ABL2.
    Qiang XF; Zhang ZW; Liu Q; Sun N; Pan LL; Shen J; Li T; Yun C; Li H; Shi LH
    J Cell Biochem; 2014 Jul; 115(7):1269-76. PubMed ID: 24464651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiRNA-30e downregulation increases cancer cell proliferation, invasion and tumor growth through targeting RPS6KB1.
    Wang L; Ji XB; Wang LH; Xia ZK; Xie YX; Liu WJ; Qiu JG; Jiang BH; Liu LZ
    Aging (Albany NY); 2021 Nov; 13(21):24037-24049. PubMed ID: 34727092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of miR-24 suppresses malignancy of human non-small cell lung cancer cells by targeting WWOX in vitro and in vivo.
    Wang XH; Gan CZ; Xie JY
    Thorac Cancer; 2018 Dec; 9(12):1583-1593. PubMed ID: 30307120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. STAT3 is involved in miR-124-mediated suppressive effects on esophageal cancer cells.
    Cheng Y; Li Y; Nian Y; Liu D; Dai F; Zhang J
    BMC Cancer; 2015 Apr; 15():306. PubMed ID: 25928665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-223-3p Inhibits Human Osteosarcoma Metastasis and Progression by Directly Targeting CDH6.
    Ji Q; Xu X; Song Q; Xu Y; Tai Y; Goodman SB; Bi W; Xu M; Jiao S; Maloney WJ; Wang Y
    Mol Ther; 2018 May; 26(5):1299-1312. PubMed ID: 29628305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-195-5p, a new regulator of Fra-1, suppresses the migration and invasion of prostate cancer cells.
    Wu J; Ji A; Wang X; Zhu Y; Yu Y; Lin Y; Liu Y; Li S; Liang Z; Xu X; Zheng X; Xie L
    J Transl Med; 2015 Sep; 13():289. PubMed ID: 26337460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Claudin-1 is a novel target of miR-375 in non-small-cell lung cancer.
    Yoda S; Soejima K; Hamamoto J; Yasuda H; Nakayama S; Satomi R; Terai H; Ikemura S; Sato T; Naoki K; Betsuyaku T
    Lung Cancer; 2014 Sep; 85(3):366-72. PubMed ID: 25001509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic silencing of miR-126 contributes to tumor invasion and angiogenesis in colorectal cancer.
    Zhang Y; Wang X; Xu B; Wang B; Wang Z; Liang Y; Zhou J; Hu J; Jiang B
    Oncol Rep; 2013 Oct; 30(4):1976-84. PubMed ID: 23900443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MTA1-activated Epi-microRNA-22 regulates E-cadherin and prostate cancer invasiveness.
    Dhar S; Kumar A; Gomez CR; Akhtar I; Hancock JC; Lage JM; Pound CR; Levenson AS
    FEBS Lett; 2017 Mar; 591(6):924-933. PubMed ID: 28231399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.